Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PHF8 | Q9UPP1 | 4/20 | 0.48 |
| ▸ | KDM2A | Q9Y2K7 | 4/20 | 0.48 |
| ▸ | KDM7A | Q6ZMT4 | 2/20 | 0.46 |
| ▸ | KDM4C | Q9H3R0 | 12/20 | 0.42 |
| ▸ | KDM5A | P29375 | 2/20 | 0.42 |
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.42 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.42 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.41 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.41 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.41 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.41 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.41 |
| ▸ | KDM6B | O15054 | 1/20 | 0.41 |
| ▸ | KDM5C | P41229 | 1/20 | 0.41 |
| ▸ | KDM4A | O75164 | 11/20 | 0.41 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | ALDH2 | P05091 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL29169413 | 0.97 | PHF8 (0.46) | PHF8KDM2AKDM7AKDM4CKDM5A | |
| Water SCHEMBL29140095 | 0.97 | PHF8 (0.46) | PHF8KDM2AKDM7AKDM4CKDM5A | |
| SCHEMBL21981942 | 0.79 | PHF8 (0.43) | PHF8KDM2AKDM7AKDM4CKDM5A | |
| SCHEMBL2806347 | 0.78 | PHF8 (0.48) | PHF8KDM2AKDM7AKDM4CKDM5A | |
| SCHEMBL29169439 | 0.77 | KMT2A (0.64) | KDM5ALMNAALDH1A1 | |
| SCHEMBL30498495 | 0.77 | — | — | |
| SCHEMBL30498494 | 0.77 | — | — | |
| SCHEMBL103874 | 0.77 | — | — | |
| SCHEMBL718216 | 0.77 | KMT2A (0.56) | PHF8KDM2AKDM7AKDM4CKDM5A | |
| Bromide SCHEMBL29169414 | 0.75 | KMT2A (0.61) | KDM5ALMNAALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117700335-A | Method for preparing pharmaceutical agent mildronate dihydrate by hydrolysis acidification improvement technology | 衣伟男 | 2024-03-15 | — | — | CN | disclosed |
| US-8889902-B2 | Acetylsalicylic acid salts | TETRA, SIA (LV) | 2014-11-18 | — | — | US | disclosed |
| US-20120088742-A1 | ACETYLSALICYLIC ACID SALTS | TETRA, SIA (LV) | 2012-04-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120088742-A1 | ACETYLSALICYLIC ACID SALTS | SLC6A12, TGFB1, CPT1A | PHF8 4133/4885KDM2A 3362/4885KDM7A 2469/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.